Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 1;20(8):670-680.
doi: 10.1093/ijnp/pyx032.

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies

Affiliations
Review

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies

Brisa Solé et al. Int J Neuropsychopharmacol. .

Abstract

Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.

Keywords: bipolar disorder; cognitive impairment; cognitive remediation; functional remediation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Neuroprogression of bipolar disorder (BD) and strategies to prevent or to treat cognitive dysfunction.

References

    1. Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O’Donovan C, Hajek T, Nair C, Dursun S, MacQueen G (2017) Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry 210:54–60. - PubMed
    1. Amoretti S, Bernardo M, Bonnin CM, Bioque M, Cabrera B, Mezquida G, Sole B, Vieta E, Torrent C (2016) The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study. Eur Neuropsychopharmacol 26:1638–1648. - PubMed
    1. Anaya C, Torrent C, Caballero FF, Vieta E, Bonnin CM, Ayuso-Mateos JL (2016) Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life. Acta Psychiatr Scand 133:386–398. - PubMed
    1. Arts B, Jabben N, Krabbendam L, van Os J (2008) Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 38:771–785. - PubMed
    1. Balanzá-Martínez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, Vieta E, Tabarés-Seisdedos R (2008) Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 32:1426–1438. - PubMed

Publication types

MeSH terms